Elevated Leukocyte Glucose Index Is Associated with Long-Term Arteriovenous Fistula Failure in Dialysis Patients

Adrian Vasile Mureșan1,2, Elena Florea2, Emil-Marian Arbănași1,2,3,4

  • 1Department of Vascular Surgery, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania.

PubMed

Insights

High leukocyte glucose index (LGI) values predict arteriovenous fistula (AVF) failure in end-stage kidney disease patients. This biomarker indicates a higher risk of vascular access dysfunction, independent of other factors.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Biomarkers

Background:

  • Arteriovenous fistula (AVF) is the preferred vascular access for dialysis in end-stage kidney disease (ESKD) patients.
  • Primary patency rates for AVF at one year are below 70% due to various risk factors and comorbidities.
  • Leukocyte glucose index (LGI), a novel biomarker, has shown associations with adverse cardiovascular outcomes.

Purpose of the Study:

  • To investigate the impact of preoperative Leukocyte glucose index (LGI) on the long-term primary patency of AVF in ESKD patients.
  • To determine if LGI can serve as a predictive biomarker for AVF failure.

Main Methods:

  • Retrospective observational study of 158 ESKD patients undergoing AVF creation for dialysis.
  • Primary endpoint: AVF failure, defined as inability to perform chronic dialysis due to restenosis or thrombosis.
  • Analysis included ROC analysis and Kaplan-Meier survival analyses to assess LGI's predictive value.

Main Results:

  • Patients with AVF failure exhibited higher LGI values (1.12 vs. 0.79, p < 0.001) and increased prevalence of atrial fibrillation and diabetes.
  • LGI demonstrated strong association with AVF failure (AUC = 0.729) with an optimal cut-off of 0.95.
  • Higher LGI tertiles and baseline LGI values correlated significantly with increased risk of AVF failure, independent of other clinical factors.

Conclusions:

  • Elevated preoperative LGI is a significant positive predictor of long-term AVF failure in ESKD patients.
  • LGI's prognostic value for AVF failure is independent of age, sex, cardiovascular risk factors, and vascular mapping.
  • LGI may be a valuable biomarker for identifying patients at high risk of AVF dysfunction.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...